APLLTDNSEALEMBIC PHARMA LTD· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 10 Aug, 2026 · 19:01 IST

Company Secretary Manisha Saraf resigns from Alembic Pharma

Kmp ResignedManagement Changes View source PDFExplain this filing

APLLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.6%Reaction day
₹834.00
prior close
₹831.35
announcement price
After-mkt
timing
Nifty Microcap 250market-0.2%+0.8% vs market
Pharmaceuticals peers, median of 164sector+0.1%+0.6% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 0.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
-0.3
15m
-0.4
30m
-0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.6-0.2+0.8+0.1+0.6
Next day
+1.2+0.2+1.0-0.5+1.7
2d
-0.4+0.4-0.7+0.1-0.5
3d
-1.1+0.4-1.5-0.4-0.7
4d
-1.2+0.6-1.8-0.9-0.3
5d
-0.9+0.9-1.8-0.5-0.4
1w
-2.3+0.9-3.1-1.0-1.3
15d
+1.2+0.9+0.3-0.8+2.0
1m
-3.2+2.3-5.6+1.1-4.4
2m
-5.3-1.1-4.2-3.1-2.2
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ms. Manisha Saraf has resigned as Company Secretary, Compliance Officer and Nodal Officer (Key Managerial Personnel) of Alembic Pharmaceuticals, effective close of business hours on 10 August 2026. She cited pursuit of a new opportunity better aligned with her long-term career aspirations. The CFO G. Krishnan signed the intimation to the exchanges. No replacement has been announced yet.

Likely market impact

Key Managerial Personnel exit; company will need to appoint a new Company Secretary. Watch for a successor announcement. Typically a routine change but may signal governance churn.